PART I: BACKGROUND
1: The Drafting History of the European Biotechnology Directive
PART II: MORALITY, RESEARCH AND ETHICS
2: Towards Commonality? Policy Approaches to Human Embryonic Stem Cell Research in Europe
3: Human Embryonic Stem Cell Research in Central and Eastern Europe: A Comparative Analysis of Regulatory and Policy Approaches
4: Morality Provisions in Law Concerning the Commercialisation of Human Embryos and Stem Cells
PART III: EUROPEAN PATENT LAW
5: A Comparative Analysis of the National Implementation of the Directive's Morality Clause
6: The Construction of the Directive's Moral Exclusions under the EPC
7: Towards Systemic Legal Conflict: Article 6(2)(c) of the Biotech Directive
8: Human Dignity, Human Rights and Article 6(1) of the Biotech Directive
9: Jurisdictional and Institutional Aspects of Stem Cell Patenting in Europe (EC and EPO): Institutional and Jurisdictional Tensions of Stem Cells Patenting in Europe
10: A Transnational Institution Confronted with a Single Jurisdiction Model: Guidance for the EPO's Implementation of the Directive from a Private International Law Perspective
PART IV: WIDER ISSUES
11: An Ethics Committee for Patent Offices
12: The Research Exemption in Patent Law and its Application to hES Cell Research
13: Human Embryos, Patents and Global Trade: Assessing the Scope and Contents of the TRIPS Morality Exception
14: Stem Cells Patenting and Competition Law